Taisho Pharmaceutical Co., Ltd.

This study tested a new medicine called TS-172 in 101 adults on hemodialysis who had high phosphorus levels. The goal was to see if the drug could help more patients reach a safe phosphorus level in their blood. Results showed that TS-172 was better than a placebo at controlling …

This early study tested a drug called TS-172 in 16 healthy Japanese men to see if taking it before or after a meal changes how the body handles phosphorus and sodium. The trial is complete and focused on safety and basic effects, not on treating any disease. It provides initial d…